Efficacy of Empagliflozin in Slowing the Progression of Renal Disease in Patients with Type 2 Diabetes: Single-Blind Interventional Study with Placebo Control at Tertiary Care Setting Quetta. Life and Science, [S. l.], v. 6, n. 4, p. 06, 2025. DOI: 10.37185/LnS.1.1.870. Disponível em: https://lifenscience.org/index.php/life-and-science/article/view/870. Acesso em: 17 oct. 2026.